AI Liquid Biopsy Platform Shows Promise for Liver Cancer Detection
Positive liver cancer detection data demonstrates the promise of Delfi Diagnostics’ liquid biopsy platform in a new tumor type.
Read More
Search Results for: liver disease
NATtrol Bacteriophage MS2 Launched by ZeptoMetrix
ZeptoMetrix, an Antylia Scientific company, launches the NATtrol Bacteriophage MS2 quantitative stock: NATMS2-STQ.
Read More
Roche Launches PRAME Antibody for Suspected Melanoma
Roche has announced the launch of the PRAME Antibody to identify PRAME protein expression with suspected melanoma.
Read More
Novel AI Blood Test Detects Liver Cancer
A new AI blood testing tech called DELFI successfully detected more than 80% of liver cancer cases in a new study.
Read More
Contactless Health Monitoring Device Can Assess Disease Risk
NuraLogix has announced that its contactless health monitoring platform, Anura, will be able to assess metabolic and blood biomarker risks.
Read More